Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63629-2240

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 63629-2240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292240)

Label for Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide Tablets, film-coated, oral dosage form. Strength is 40 mg / 10 mg / 12.5 mg per tablet. The label shows the NDC 63629-2240-1 with Bryant Ranch Prepack as the labeler. Contains directions for storage and child-resistant packaging information. Package count is 90 tablets.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure of olmesartan medoxomil, a component of the combination drug olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide. The diagram shows the molecular framework with rings and functional groups characteristic to olmesartan medoxomil.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure diagram of the active ingredients olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide as per product data for the oral tablet formulation.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure of olmesartan medoxomil depicted as a molecular diagram with labeled atoms and bonds showing its specific chemical framework.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

A line chart illustrating comparative data over time with five distinct series: Baseline, 40/10, 40/HCTZ25, 10/HCTZ25, and 40/10/HCTZ25. The vertical axis ranges approximately from 55 to 100, while the horizontal axis represents a sequential timeline or measurement intervals. Each series is represented by different marker symbols and line styles for distinction.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing mean systolic blood pressure (mmHg) on the vertical axis versus hours post dose (0 to 24) on the horizontal axis. The graph displays baseline and various treatment groups with different combinations of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) over 24 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.